These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2426198

  • 1. Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.
    Manning PA, Heuzenroeder MW, Yeadon J, Leavesley DI, Reeves PR, Rowley D.
    Infect Immun; 1986 Aug; 53(2):272-7. PubMed ID: 2426198
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharides of Escherichia coli K12 strains that express cloned genes for the Ogawa and Inaba antigens of Vibrio cholerae O1: identification of O-antigenic factors.
    Hisatsune K, Kondo S, Iguchi T, Ito T, Hiramatsu K.
    Microbiol Immunol; 1996 Aug; 40(9):621-6. PubMed ID: 8908606
    [Abstract] [Full Text] [Related]

  • 3. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S, Boutonnier A, Mulard LA, Fournier JM.
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [Abstract] [Full Text] [Related]

  • 4. Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model.
    Mukherjee P, Mondal V, Bhaumik U, Sinha R, Sarkar S, Mitra S, Howlader DR, Maiti S, Mukhopadhyay AK, Dutta S, Koley H.
    Microbes Infect; 2019 Sep; 21(8-9):368-376. PubMed ID: 30853357
    [Abstract] [Full Text] [Related]

  • 5. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.
    Vaccine; 2011 Oct 06; 29(43):7505-13. PubMed ID: 21807059
    [Abstract] [Full Text] [Related]

  • 6. Effect of lipopolysaccharide core synthesis mutations on the production of Vibrio cholerae O-antigen in Escherichia coli K-12.
    Morona R, Brown MH, Yeadon J, Heuzenroeder MW, Manning PA.
    FEMS Microbiol Lett; 1991 Aug 15; 66(3):279-85. PubMed ID: 1722766
    [Abstract] [Full Text] [Related]

  • 7. Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies.
    Gustafsson B, Holme T.
    Eur J Clin Microbiol; 1985 Jun 15; 4(3):291-4. PubMed ID: 2410265
    [Abstract] [Full Text] [Related]

  • 8. Regions of the cloned Vibrio cholerae rfb genes needed to determine the Ogawa form of the O-antigen.
    Morona R, Matthews MS, Morona JK, Brown MH.
    Mol Gen Genet; 1990 Dec 15; 224(3):405-12. PubMed ID: 1702506
    [Abstract] [Full Text] [Related]

  • 9. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA, Jansen WH, Rijpkema SG.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov 15; 270(1-2):260-9. PubMed ID: 2464884
    [Abstract] [Full Text] [Related]

  • 10. Serotype conversion in Vibrio cholerae O1.
    Stroeher UH, Karageorgos LE, Morona R, Manning PA.
    Proc Natl Acad Sci U S A; 1992 Apr 01; 89(7):2566-70. PubMed ID: 1372980
    [Abstract] [Full Text] [Related]

  • 11. Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.
    Karlsson SL, Ax E, Nygren E, Källgård S, Blomquist M, Ekman A, Benktander J, Holmgren J, Lebens M.
    PLoS One; 2014 Apr 01; 9(11):e108521. PubMed ID: 25397871
    [Abstract] [Full Text] [Related]

  • 12. Construction and characterization of a potential live oral carrier-based vaccine against Vibrio cholerae O139.
    Favre D, Cryz SJ, Viret JF.
    Infect Immun; 1996 Sep 01; 64(9):3565-70. PubMed ID: 8751900
    [Abstract] [Full Text] [Related]

  • 13. A physical map of the chromosomal region determining O-antigen biosynthesis in Vibrio cholerae O1.
    Ward HM, Morelli G, Kamke M, Morona R, Yeadon J, Hackett JA, Manning PA.
    Gene; 1987 Sep 01; 55(2-3):197-204. PubMed ID: 2444496
    [Abstract] [Full Text] [Related]

  • 14. Identification and nucleotide sequence determination of the gene responsible for Ogawa serotype specificity of V. cholerae 01.
    Ito T, Ohshita Y, Hiramatsu K, Yokota T.
    FEBS Lett; 1991 Jul 29; 286(1-2):159-62. PubMed ID: 1713857
    [Abstract] [Full Text] [Related]

  • 15. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X, Ma Q.
    Chin J Biotechnol; 1994 Jul 29; 10(4):225-32. PubMed ID: 7780018
    [Abstract] [Full Text] [Related]

  • 16. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL, Schild S, Patimalla B, Klein B, Camilli A.
    Infect Immun; 2010 Oct 29; 78(10):4402-20. PubMed ID: 20679439
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the rfbT gene are responsible for the Ogawa to inaba serotype conversion in Vibrio cholerae O1.
    Ito T, Hiramatsu K, Ohshita Y, Yokota T.
    Microbiol Immunol; 1993 Oct 29; 37(4):281-8. PubMed ID: 7688846
    [Abstract] [Full Text] [Related]

  • 18. [Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar].
    Toporkov AV, Zadnova SP, Smirnova NI.
    Zh Mikrobiol Epidemiol Immunobiol; 2005 Oct 29; (1):53-7. PubMed ID: 15773401
    [Abstract] [Full Text] [Related]

  • 19. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.
    Wang J, Villeneuve S, Zhang J, Lei P, Miller CE, Lafaye P, Nato F, Szu SC, Karpas A, Bystricky S, Robbins JB, Kovác P, Fournier JM, Glaudemans CP.
    J Biol Chem; 1998 Jan 30; 273(5):2777-83. PubMed ID: 9446585
    [Abstract] [Full Text] [Related]

  • 20. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].
    Smirnova NI, Livanova LF, Chekhovskaia GV, Eroshenko GA, Lazovskiĭ IuV, Zakharova TL.
    Zh Mikrobiol Epidemiol Immunobiol; 2000 Jan 30; (3):47-51. PubMed ID: 10925874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.